Literature DB >> 3043455

The therapeutic use of I-131 meta-iodobenzylguanidine (mIBG) in neuroblastoma: a phase II study in 12 patients.

O Hartmann1, J D Lumbroso, M Lemerle, M Schlumberger, M Ricard, B Aubert, S Coornaert, L Merlin, C Parmentier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3043455

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  2 in total

1.  [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.

Authors:  T Klingebiel; J Treuner; G Ehninger; K D Keller; R Dopfer; U Feine; D Niethammer
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N.

Authors:  Fredrik Sundquist; Kleopatra Georgantzi; Kirsten Brunsvig Jarvis; Jesper Brok; Minna Koskenvuo; Jelena Rascon; Max van Noesel; Per Grybäck; Joachim Nilsson; Arthur Braat; Mikael Sundin; Sandra Wessman; Nikolas Herold; Lars Hjorth; Per Kogner; Dan Granberg; Mark Gaze; Jakob Stenman
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.